Recombinant rabbit monoclonal antibodies are produced using in vitro expression systems. The expression systems are developed by cloning in the specific antibody DNA sequences from immunoreactive rabbits. Then, individual clones are screened to select the best candidates for production. The advantages of using recombinant rabbit monoclonal antibodies include: better specificity and sensitivity, lot-to-lot consistency, animal origin-free formulations, and broader immunoreactivity to diverse targets due to larger rabbit immune repertoire.
For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.
Protein Aliases: Activating transcription factor 1; cAMP-dependent transcription factor ATF-7; Cyclic AMP-dependent transcription factor ATF-1; cyclic AMP-dependent transcription factor ATF-7; Protein TREB36; transcription factor ATF-A
Gene Aliases: 1110012F10Rik; 9430065F09Rik; AI549878; ATFA; C130020M04Rik